Brokerages Set Sotera Health Company (NASDAQ:SHC) PT at $20.00

Shares of Sotera Health Company (NASDAQ:SHC) have been given a consensus recommendation of “Moderate Buy” by the ten research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $20.00.

A number of brokerages recently weighed in on SHC. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. William Blair initiated coverage on Sotera Health in a research report on Thursday, December 18th. They issued an “outperform” rating for the company. Barclays raised their target price on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Wells Fargo & Company cut Sotera Health to an “overweight” rating in a report on Thursday, January 8th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th.

Sotera Health Stock Performance

Shares of SHC opened at $17.12 on Thursday. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04. Sotera Health has a 52-week low of $9.53 and a 52-week high of $19.85. The company has a 50-day simple moving average of $17.92 and a 200-day simple moving average of $16.52. The company has a market capitalization of $4.86 billion, a PE ratio of 90.11 and a beta of 1.82.

Insider Activity at Sotera Health

In other Sotera Health news, Director Pincus & Co. Warburg sold 9,720,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the completion of the sale, the director owned 34,102,952 shares in the company, valued at $556,901,206.16. This trade represents a 22.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total value of $105,818,400.00. Following the completion of the transaction, the director directly owned 22,735,301 shares in the company, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 17,384,104 shares of company stock valued at $284,024,511. Insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds have recently added to or reduced their stakes in SHC. IFP Advisors Inc raised its stake in Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares during the period. Rothschild Investment LLC bought a new position in shares of Sotera Health during the fourth quarter valued at approximately $27,000. True Wealth Design LLC raised its position in shares of Sotera Health by 389.3% during the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after purchasing an additional 1,456 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new position in Sotera Health during the 4th quarter valued at approximately $40,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.